Lexeo Therapeutics Inc
NASDAQ:LXEO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Lexeo Therapeutics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Lexeo Therapeutics Does
Lexeo Therapeutics is a biotechnology company that develops gene therapies for serious diseases caused by faulty genes. Its main work is to design and test one-time treatments that use viral vectors to deliver working copies of genes into a patient’s cells. The company focuses on diseases in areas such as the heart and the nervous system, where there are often few good treatment options.
- Headquarters
- United States of America US
- Employees
- 59
- IPO date
- Nov 3, 2023
Continue LXEO Research
Decided on Lexeo Therapeutics? Get an email when LXEO reaches the price you’d buy at. Free with an account.